TP53 and colorectal carcinoma: Huang et al. showed that lncRNA TP73-AS1 interacts with KDM5A to promote CRC malignant behavior by affecting TP53 transcription, whereas treatment with the KDM5A inhibitor HY-100014 reduced KDM5A occupancy at the TP53 promoter [148].